| Antigen: |
Decay Accelerating Factor (DAF); CD55 |
| Relevance: |
CD55 is a distinctive marker of synovium. CD55 protects tissues from attack by autologous complement by interfering with the assembly of C3 convertase. |
| Clone: |
67 |
| Subclass: |
IgG1 |
| Applications: |
Immunohistochemistry (Acetone Fixed, Frozen) |
| Immunogen: |
Fibronectin purified monocytes |
| Reactivity: |
- |
| Species raised in: |
- |
| Fusion partner: |
Sp2/0 |
| Recommended growth conditions: |
DMEM + 5% FCS |
| References: |
Palmer DG et al. 1985. Clin. Exp. Immunol. 59:529-538. 
Leitinger B et a. 2002. J. Cell. Sci. 115:963-72 |
| Notes: |
- |
For further information about antibodies from CRT or to discuss sales or licensing options, please contact us at reagents@cancertechnology.com
Please note that CRT supplies to distributors only. However, we are happy to direct researchers to the appropriate commercial party to obtain antibodies within our portfolio. Click here to view disclaimer information. |
